EP2982690

ABLYNX N.V.
Application Number
EP15174570A
Filing Date
Apr 30, 2010
Status
Opposition Rejected
Jan 5, 2024
Grant Date
Jan 27, 2021
External Links
Slate, Register

Biblio Summary

The patent EP2982690B1 was granted on Jan 27, 2021 by Ablynx N.V. The patent is currently Opposition Rejected.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EIP LIMITEDJan 27, 2021 N.A.

The table below shows the patents of Ablynx N.V. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3143042Improved Immunoglobulin Variable DomainsJun 10, 20201
EP3049439Bispecific NanobodiesDec 25, 20191
EP2632946Method For The Production Of Immunoglobulin Single Variable DomainsDec 6, 20171